Literature DB >> 18586485

Analysis of sternotomy as treatment option for the resection of bilateral pulmonary metastases in pediatric solid tumors.

Jörg Fuchs1, Guido Seitz, Verena Ellerkamp, Klaus Dietz, Axel Bosk, Ingo Müller, Steven W Warmann, Jürgen F Schäfer.   

Abstract

BACKGROUND: Radical surgical resection of metastases is an important prognostic factor for survival of patients suffering from solid pediatric tumors. The aim of this study is to evaluate the efficacy of median sternotomy as treatment option for the resection of multiple bilateral lung metastases in children with different tumor entities. Furthermore, the sensitivity of preoperative imaging (CT) was assessed by intraoperative findings. PATIENTS AND METHODS: Between 2002 and 2007, 13 children (4 with sarcoma, 4 with nephroblastoma, 5 with hepatoblastoma) underwent median sternotomy for resection of bilateral lung metastases after R0-resection of the primary tumor. In 6/13 cases, the sternotomy was combined with the primary tumor resection.
RESULTS: Median patient age at the first operation was 5 years (range: 11 months to 17 years). The median total number of resected metastases per operation was 9 and ranged from 0 to 65. In 13/16 operations, the intraoperative number of metastases did not agree with the preoperative radiological work-up. Median hospital stay was 14 days (range from 9 to 36 days). Ten out of 13 children are alive after a median follow-up of 13 months (range from 6 to 66 months).
CONCLUSION: Median sternotomy is an adequate treatment modality for the resection of bilateral pulmonary metastases as a one-stage procedure. The combination of primary tumor resection with sternotomy should be considered as a treatment option. Complete resection of metastases of solid pediatric tumors should be aimed for in order to increase the survival of these patients.

Entities:  

Mesh:

Year:  2008        PMID: 18586485     DOI: 10.1016/j.suronc.2008.05.004

Source DB:  PubMed          Journal:  Surg Oncol        ISSN: 0960-7404            Impact factor:   3.279


  8 in total

Review 1.  The role of minimally invasive surgery in pediatric solid tumors.

Authors:  Jörg Fuchs
Journal:  Pediatr Surg Int       Date:  2015-01-15       Impact factor: 1.827

2.  Thoracoscopic resection of solitary lung metastases evaluated by using thin-section chest computed tomography: is thoracoscopic surgery still a valid option?

Authors:  Kook Nam Han; Chang Hyun Kang; In Kyu Park; Young Tae Kim
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-07-07

Review 3.  [Simultaneous whole-body PET-MRI in pediatric oncology : More than just reducing radiation?].

Authors:  S Gatidis; B Gückel; C la Fougère; J Schmitt; J F Schäfer
Journal:  Radiologe       Date:  2016-07       Impact factor: 0.635

4.  International Society of Paediatric Surgical Oncology (IPSO) Surgical Practice Guidelines.

Authors:  Simone de Campos Vieira Abib; Chan Hon Chui; Sharon Cox; Abdelhafeez H Abdelhafeez; Israel Fernandez-Pineda; Ahmed Elgendy; Jonathan Karpelowsky; Pablo Lobos; Marc Wijnen; Jörg Fuchs; Andrea Hayes; Justin T Gerstle
Journal:  Ecancermedicalscience       Date:  2022-02-17

Review 5.  Surgical treatment of pulmonary metastases in pediatric solid tumors.

Authors:  Todd E Heaton; Andrew M Davidoff
Journal:  Semin Pediatr Surg       Date:  2016-09-03       Impact factor: 2.754

Review 6.  Molecular alterations as target for therapy in metastatic osteosarcoma: a review of literature.

Authors:  J PosthumaDeBoer; M A Witlox; G J L Kaspers; B J van Royen
Journal:  Clin Exp Metastasis       Date:  2011-04-02       Impact factor: 5.150

7.  Bilateral anterior sternothoracotomy (clamshell incision): a suitable alternative for bilateral lung sarcoma metastasis in children.

Authors:  Olivier Abbo; Ramona Guatta; Kalitha Pinnagoda; Jean-Marc Joseph
Journal:  World J Surg Oncol       Date:  2014-07-27       Impact factor: 2.754

Review 8.  Minimally invasive surgery for pediatric tumors - current state of the art.

Authors:  Jörg Fuchs; Luana Schafbuch; Martin Ebinger; Jürgen F Schäfer; Guido Seitz; Steven W Warmann
Journal:  Front Pediatr       Date:  2014-06-03       Impact factor: 3.418

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.